[Clinicopathological Features and Outcomes of Perioperative Treatment for Small Cell Carcinoma of the Bladder].
RC is an effective treatment that prolongs the survival of patients with limited-stage SCCB. RS combined with NAT can further improve their survival.
Authors
- Mengni Zhang (ORCID: https://orcid.org/0000-0001-7437-5209)
- Yali Shen (ORCID: https://orcid.org/0000-0001-6416-9516)
- Peng Zhang (ORCID: https://orcid.org/0009-0007-0631-7761)
- Jing Deng (ORCID: https://orcid.org/0000-0003-0395-8815)
- Miao Yang (ORCID: https://orcid.org/0000-0003-0165-7584)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-09-20
- DOI
- https://doi.org/10.12182/20240960501
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article